Radioiodine therapy offers curative treatment for feline hyperthyroidism with welfare advantages over lifelong medication.
Cats requiring twice-daily medication for hyperthyroidism management experience repeated handling stress associated with pilling or medication administration. Owner compliance is variable leading to inconsistent treatment and persistent disease. Radioiodine therapy that cures the condition with single treatment eliminates the ongoing welfare burden of medication management. Where accessible, it represents a welfare-positive alternative to lifetime medication for most cats.